Botulinum toxin pharmaceutical compositions

Details for Australian Patent Application No. 2005203171 (hide)

International Classifications

Event Publications

4 August 2005 Complete Application Filed

11 August 2005 Application Open to Public Inspection

Published as AU-B-2005203171

24 November 2005 Section 223 Application Received

Allergan, Inc. An application to extend the time from 08 Oct 2004 to 08 Aug 2005 in which to make a further application for a divisional patent has been filed . Address for service in Australia - Davies Collison Cave Level 10 10 Barrack Street Sydney NSW 2000

19 January 2006 Section 223 Application Allowed

Allergan, Inc. The time in which to make a further application for a divisional patent has been extended to 08 Aug 2005. Address for service in Australia - Davies Collison Cave Level 10 10 Barrack Street Sydney NSW 2000

13 December 2007 Application Accepted

Published as AU-B-2005203171

31 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2E(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

22 May 2008 Section 223 Application Allowed

Allergan, Inc. The time in which to pay the examination response fees has been extended to 07 Feb 2008. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000 2006

12 June 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.